Status:
COMPLETED
Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy
Lead Sponsor:
Khyber Medical University Peshawar
Conditions:
Peripheral Diabetic Neuropathy
Eligibility:
All Genders
40-60 years
Phase:
PHASE2
Brief Summary
Type 2 DM subjects having numbness, tingling and paresthesia in hands and feet (neuropathy) will be recruited. Screening of neuropathy will be done by Michigan screening instrument. This will be follo...
Detailed Description
Type 2 DM subjects having numbness, tingling and paresthesia in hands and feet (neuropathy) will be recruited. They will be screened by Michigan neuropathy scale. This is tool used for screening neuro...
Eligibility Criteria
Inclusion
- Patients with Type 2 Diabetes Mellitus
- Age between 40-60 years
Exclusion
- Malignancy
- Vitamin B12 deficiency
- History of drug or alcohol abuse
- Taking antioxidant treatment
- History and baseline investigations for renal hepatic and haematological diseases
- Pregnant or lactating women.
Key Trial Info
Start Date :
January 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06131918
Start Date
January 9 2023
End Date
May 5 2024
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Syed Hamid Habib
Peshawar, KPK, Pakistan